Please visit the following to learn more about these clinical trials.
- MD Anderson Study Summary ID01-022
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Read about the Ovarian Cancer Low Risk Study.
- MD Anderson Study Summary ID02-115
A Phase II Study to Evaluate the Maximum Biologic Dose of Pegylated-Interferon (PEG INTRON) in Patients with Platinum-Resistant Ovarian, Peritoneal or Fallopian Tube Cancer
- MD Anderson Study Summary ID02-321
A Phase 1/2 Randomized Study of Intraperitoneal tgDCC-E1A and Intravenous Paclitaxel in Women with Platinum-Resistant Ovarian Cancer